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Chung Sim Lim, MRCS, PhD,a,b Serafim Kiriakidis, PhD,b Ewa M. Paleolog, PhD,b and
Alun H. Davies, DM, FRCS,a London, United Kingdom
Background: Doxycycline and micronized purified flavonoid fraction (MPFF) modulate vein wall remodeling that may be
associated with hypoxia in varicose veins (VVs), vein graft stenosis, and deep venous thrombosis. We recently reported that in
vitro exposure of non-VV (NVVs) and VVs to hypoxic conditions activates the hypoxia-inducible factor (HIF) pathway. This
study investigated the in vitro effects of doxycycline and MPFF on the HIF pathway in hypoxic NVVs and VVs.
Methods: Six NVVs and six VVs obtained from surgery were used to prepare vein organ cultures, which were exposed to
hypoxia (1%O2), with and withoutMPFF (10–5 mol/L) or doxycycline (5g/mL) for 16 hours. The veins were analyzed
for HIF-1, HIF-2, and their target gene expression, with real-time polymerase chain reaction and Western blot. The
differences between gene expressions were tested with one-way analysis of variance with repeated measures, followed by
the Dunnett test for multiple comparisons. P < .05 was considered significant.
Results: Treatment of NVV organ cultures exposed to hypoxia with doxycycline or MPFF did not significantly alter the
expression of HIF-1 and HIF-2 messenger (m)RNA and protein compared with untreated. Doxycycline also did not
significantly affect the expression of HIF-1 and HIF-2mRNA and protein in VVs exposed to hypoxia compared with
untreated VVs. However, MPFF significantly reduced the expression of HIF-1 but not HIF-2mRNA in VVs exposed
to hypoxia compared with untreated VVs. Interestingly, the reduction of the expression of HIF-1 mRNA in VVs by
MPFF was not reflected at the protein level. The mRNA expression of HIF target genes, namely glucose transporter-1,
carbonic anhydrase-9, vascular endothelial growth factor, B-cell lymphoma 2/adenovirus E1B 19-kDa protein-interact-
ing protein 3, prolyl hydroxylase domain-2, and prolyl hydroxylase domain-3, was not significantly altered in NVVs and
VVs exposed to hypoxia and treated with doxycycline or MPFF compared with those untreated.
Conclusions:Doxycycline and MPFF at a concentration corresponding to a therapeutic dose do not alter the activation of
the HIF pathway in NVV and VV organ cultures exposed to hypoxia. Our findings suggest vein wall remodeling actions
in NVVs and VVs are likely not HIF-dependent. ( J Vasc Surg 2012;56:1069-77.)
Clinical Relevance. Vein wall remodeling is associated with common venous-related pathology, including varicose veins, vein
graft stenosis, and deep vein thrombosis. Modifying vein wall remodeling, including with pharmacologic agents, is an
attractive potential therapeutic strategy for these diseases. Doxycycline and micronized purified flavonoid fraction are known
tomodulate veinwall remodeling through inhibition ofmatrixmetalloproteases and anti-inflammatory processes, respectively.
However, the exact nature of the upstream regulation of their activities remains unclear. This study examined the effects of
doxycycline and micronized purified flavonoid fraction on the hypoxia-inducible factor pathway in hypoxic venous tissues;
however, our findings suggest that their vein wall remodeling actions do not likely depend on hypoxia-inducible factor.
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CAlteration in oxygen tension is known to contribute to
various cardiovascular pathologies.1,2 In pathologies in-
volving venous tissues, such as vein graft stenosis, varicose
From the Academic Section of Vascular Surgery, Department of Surgery and
Cancer,a and Cytokine Biology of Vessels, Kennedy Institute of Rheuma-
tology,b Faculty of Medicine, Imperial College London.
Dr Lim was awarded a Research Fellowship from the Royal College of
Surgeons of England and Rosetrees’ Trust, and received research grants
from the European Venous Forum, Graham-Dixon Charitable Trust, and
European Society for Vascular Surgery.
Author conflict of interest: none.
Presented at the Twenty-fourth Annual Meeting of the American Venous
Forum, Orlando, Fla, February 8-11, 2012.
heins (VVs), and venous thrombosis, hypoxia has been
ostulated to contribute to vein wall remodeling that in-
ludes intimal hyperplasia, changes in smooth muscle cell
eprint requests: Alun H. Davies, 4 East, Charing Cross Hospital, Fulham
Palace Rd, London W6 8RF, UK (e-mail: a.h.davies@imperial.ac.uk).
he editors and reviewers of this article have no relevant financial
relationships to disclose per the JVS policy that requires reviewers to
decline review of any manuscript for which they may have a conflict of
interest.
741-5214/$36.00
opyright © 2012 by the Society for Vascular Surgery.
ttp://dx.doi.org/10.1016/j.jvs.2012.02.067
1069
n
v
d
r
o
u
p
e
s
w
i
p
i
V
V
a
v
p
i
P
w
p
p
m
m
a
T
u
A
S
S
M
T
C
JOURNAL OF VASCULAR SURGERY
October 20121070 Lim et alfunction, disruption of matrix metabolism, and alteration
of venous tone.3-7
Increased activation of the hypoxia-inducible factor
(HIF) pathway may be associated with some of these vein
wall-related pathologies.4,8,9 HIFs are nuclear transcrip-
tional factors, consisting of  and  subunits, that regulate
the transcription of various genes mediating oxygen ho-
meostasis.1,8 Under normoxia, HIF- protein subunits are
hydroxylated on proline and asparagine residues by HIF-
prolyl hydroxylase domains (PHDs) and factor-inhibiting
HIF-1 (FIH-1), respectively.10,11Hydroxylation of proline
and asparagine residues of HIF- will lead to proteosome
degradation of HIF- and negatively regulate HIF- trans-
activation activity, respectively.10,11 In hypoxia, oxygen-
dependent hydroxylation activity of PHDs and FIH-1 are
suppressed, causing stabilization of HIF-.12,13 HIF-
dimerizes withHIF- in the nucleus and binds the hypoxia-
responsive element of target genes, activating their tran-
scription.10,11 Genes regulated by the HIF pathway are
involved in different cellular functions, including angiogen-
esis, glucose metabolism, apoptosis and survival, pH regu-
lation, matrix metabolism, and vascular tone.1,8
Doxycycline and micronized purified flavonoid frac-
tions (MPFF) have been postulated to protect the vein wall
from several changes that could potentially be driven by
hypoxia.14,15 Doxycycline, a tetracycline analog, inhibits
intimal hyperplasia that may contribute to vein graft steno-
sis, likely through inhibition of matrix metalloprotease
(MMP) enzymes.14 MPFF is a venoactive drug consisting
of 90% diosmin and 10% hesperidin.16 Several mechanisms
of action have been postulated for MPFF, including inhib-
iting inflammation by reducing the expression of adhesion
molecules, increasing venous tone, and protecting endo-
thelial responses to hypoxic stress in chronic venous dis-
ease.15–17
Despite this, the upstream regulation of the vein wall
remodeling activities of doxycycline and MPFF remains
unclear. We recently demonstrated that VVs and non-VVs
(NVVs) increased the activation of the HIF pathway when
exposed to in vitro hypoxic conditions.8 Therefore, this
study aimed to investigate if in vitro treatment of hypoxic
NVVs and VVs with doxycycline and MPFF at a concen-
tration corresponding to a therapeutic dose affects the
activity of the HIF pathway. The activity of the HIF path-
way was assessed by analyzing the expression of HIF-1
and HIF-2 and also HIF target genes; namely, carbonic
anhydrase-9 (CA-9), glucose transporter-1 (GLUT-1), vas-
cular endothelial growth factor (VEGF), B-cell lymphoma
2(BCL2)/adenovirus E1B 19-kDa protein-interacting
protein 3 (BNIP-3), as well as PHD-2 and PHD-3.
METHODS
Ethical approval for this study was obtained from the
Riverside Research Ethics Committee (RREC3092), Lon-
don, United Kingdom.
Patient recruitment and tissue collection. NVVs
were obtained from patients with no history of VVs who
were undergoing arterial bypass grafting with great saphe- sous vein or arteriovenous fistula formation with cephalic
ein. The NVVs were not routinely scanned for reflux with
uplex ultrasound imaging, although the patients were
outinely asked and clinically examined for varicosities pre-
peratively. Primary VVs were retrieved from patients who
nderwent open surgery or endovenous treatment with
hlebectomies for VVs. The VVs used were refluxing dis-
ased truncal veins or their tributaries in any location of the
uperficial venous system of the leg. The patients with VVs
ere scanned with duplex ultrasound imaging while stand-
ng, and refluxing veins weremarked by vascular researchers
reoperatively. Reflux was defined as retrograde flow last-
ng 0.5 seconds.
The study excluded patients with a history of secondary
Vs, including deep venous thrombosis and congenital
Vs, connective tissue disease, vasculitis, and rheumatoid
rthritis. The demographic data, medical history, type of
ein, and the CEAP clinical classification of the recruited
atients are presented in Table I.
Tissues collected were transported in Dulbecco’s Mod-
fied Eagle’s Medium (DMEM; PAA Laboratories GmbH,
asching, Austria) to the laboratory. Vein organ cultures
ere prepared 1 hour from the time of retrieval from the
atient.
Vein organ culture. Organ cultures of NVVs (six
atients) and VVs (six patients) were prepared using a
odel previously described by Soyombo et al,18 with some
odifications. Briefly, veins were cut open longitudinally
nd transversely to expose the endothelial surface and dis-
able I. Demographic data of patients whose veins were
sed for vein organ culture
Variables
Nonvaricose veins
(n  6)
Varicose veins
(n  6)
ge, mean (range) year 64.2 (45-72) 47.5 (33-63)
ex, No.
Male 5 3
Females 1 3
moking history, No.
Nonsmokers 2 3
Former smokers 2 1
Smokers 2 2
edical history, No.
Cardiac disease 3 1
Diabetes mellitus 2 0
Peripheral arterial disease 5 0
Hypertension 5 0
ype of vein, No.
Saphenous or tributaries 5 6
Arm 1 0
EAP C class
C0-1 6 0
C2 0 0
C3 0 3
C4a 0 2
C4b 0 0
C5 0 1
C6 0 0ected into 0.5-  0.5-cm segments. Each segment was
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Volume 56, Number 4 Lim et al 1071pinned out with A1 minuten pins (Watkins and Doncaster,
Kent, UK) at the four corners, with the endothelial surface
uppermost, onto a polyester mesh (Sericol Limited, Kent,
UK) resting on Sylgard resin (Dow Corning, Seneffe, Bel-
gium) in a glass Petri dish (DURANGroupGmbH,Mainz,
Germany).
The culture medium used was 5 mL DMEM high
glucose (4.5g/L) with L-glutamine, and sodium pyruvate
(PAA Laboratories GmbH, Pasching, Austria) with 100
U/mL penicillin, 0.1 mg/mL streptomycin (PAA Labora-
tories), and 10% fetal bovine serum (Gibco, Invitrogen Life
Sciences, Paisley, UK). The viability of this vein organ
culture has been validated with cell death assay by our
department.19
Five vein organ cultures were prepared for every pa-
tient, and each culture was subjected to one of the follow-
ing: (1) normoxia (95% air with 5% CO2), (2) hypoxia (1%
O2) only, (3) hypoxia and doxycycline hyclate (5 g/mL;
Sigma-Aldrich Ltd, Gillingham, UK), (4) hypoxia and di-
methyl sulfoxide ([DMSO] 0.02% [v/v]; Sigma-Aldrich
Ltd), and (5) hypoxia andMPFF (10–5 mol/L; Daflon, gift
fromDr Pascale Deloffre, Les Laboratoires Servier, France)
plus DMSO (0.02% [v/v]). DMSO was used as a vehicle
control for MPFF because it is not soluble in water. After
16 hours, the organ cultures were immediately snap-frozen
in liquid nitrogen and stored at –80°C for real-time quan-
titative polymerase chain reaction (Q-PCR) and Western
blot analysis.
RNA isolation and real-time PCR. For RNA analy-
sis, total RNA from VV and NVV organ cultures was
isolated using RNA-Bee (AMS-Biotechnology Ltd, Oxon,
UK). Total RNA (0.5 g) was reverse transcribed using
Moloney Murine Leukemia Virus Reverse Transcriptase
(Promega, Southampton, UK) and analyzed by Q-PCR
using a thermocycler Rotor-Gene 6000 Multiplexing Sys-
Table II. Primers and sequences
Primer Orientation
HIF-1 Forward 5’-CAC
Reverse 5’-GGC
HIF-2 Forward 5’-CCT
Reverse 5’-TTC
CA-9 Forward 5’-GCT
Reverse 5’-CCA
BNIP-3 Forward 5’-GAT
Reverse 5’-CGC
GLUT-1 Forward 5’-TGG
Reverse 5’-CCA
VEGF Forward 5’-CTT
Reverse 5’-CTG
PHD-2 Forward 5’-GCA
Reverse 5’-CCA
PHD-3 Forward 5’-TTG
Reverse 5’-CGT
18S RNA Forward 5’-GTA
Reverse 5’-CCA
BNIP-3, B-cell lymphoma 2/adenovirus E1B 19-kDa protein-interacting p
-2, hypoxia-inducible factor subunits 1 and 2 PHD-2, -3; prolyl hydroxtem (Corbett Research, Qiagen, West Sussex, UK). The erimers used are listed in Table II. The messenger (m)RNA
xpression was calculated using the 2–Ct method in rela-
ion to the corresponding vein organ culture exposed to
ormoxia only. The relative mRNA expression was normal-
zed to 18S RNA as the housekeeping gene.
Protein extraction and Western blot. Whole vein
rgan cultures were homogenized in ice-cold urea buffer (8
ol/L) containing (v/v) glycerol, 1:10; 1 mol/L dithio-
hreitol, 1:1000; 1 mol/L Tris (pH 6.8), 1:100; 20%
odium dodecyl sulfate, 1:20; 0.1 mol/L stock of phenyl-
ethylsulfonyl fluoride, 1:200; and 50 mmol/L complete
ini-ethylenediaminetetraacetic acid-free protease inhibi-
or cocktail, 1:100 (Roche Applied Science).
The homogenates were centrifuged at 13,000 rpm for
minutes at 4°C. The total extracted protein concentration
as assayed using the BCA Protein Assay Kit (Thermo
cientific, Rockford, Ill). Equal amounts of protein extract
40 g in each well) were resolved by sodium dodecyl
ulfate polyacrylamide gel electrophoresis and transferred
nto polyvinylidene difluouride membranes (Millipore,
illerica, Mass). Membranes were blocked with phosphate-
uffered saline with 5% nonfat drymilk and probedwith the
ollowing primary antibodies: mouse monoclonal anti-
IF-1 (1:250; BD Transduction Laboratories, Heidel-
erg, Germany), mouse monoclonal anti-HIF-2 (1:250;
ovus Biologicals, Littleton, Colo), and rabbit polyclonal
nti-extracellular signal-regulated kinase 2 (1:500; Santa
ruz Biotechnology, Santa Cruz, Calif). Bound antibody
as detected with appropriate horseradish peroxidase con-
ugated secondary antibodies (DakoCytomation, Glostrup,
enmark) and ECL Plus Western Blotting Detection Sys-
em (GEHealthcare, Buckinghamshire, UK). Extracellular
ignal-regulated kinase 2 was used as the loading control in
he Western blot runs to ensure equal loading of protein
Sequence Product size (bp)
TGGACTTGCCTTTC-3’ 194
ATCTCGAGACTTTT-3’
GACAAGGTCTGCA-3’ 190
GTTTCCACATCAA-3’
ACCAGCGTCGCGT(T) -3’ 100
TCGGCTACCTCTGCT-3’
GATTGGTCAAGTCGG-3’ 101
TGTTCCTCATGCT-3’
GGCGGGTTGT-3’ 63
TAGCTGCTCCAGC-3’
TTGCTGCTCTACCT-3’ 282
GTGATGTTGGACT-3’
CACCGGGAAGTT-3’ 178
TCCCGTTACAGT-3’
TGCCAAGCTACA-3’ 125
GGTTCCTACGATCT-3’
GTTGAACCCCA-3’ 152
AATCGGTAGTAGCG-3’
3; CA-9, carbonic anhydrase-9; GLUT-1, glucose transporter-1; HIF-1,
omain-2, and domain-3; VEGF, vascular endothelial growth factor.CTC
TGC
TCAA
ATCC
GTC
GTC
ATGG
TCG
CAT
GGG
GCC
CATG
CGA
GCT
GGA
GTG
ACCC
TCC
roteinxtract in the wells.
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formed with GraphPad Prism 5.00 software (GraphPad
Software, San Diego, Calif). Data on relative mRNA ex-
pression represent mean standard error of the mean. The
differences in the relative mRNA expression between the
different treatment groups were tested with one-way anal-
ysis of variance with repeated measures, followed by the
Dunnett test for multiple comparisons, and separately with
paired t-test for individual comparisons of all groups. The
overall P value of one-way analysis of variance analysis of
each gene expression is presented with the individual graph.
P 	 .05 was considered significant.
RESULTS
Doxycycline and MPFF do not affect HIF-1 and
HIF-2 expression in NVV and VV organ cultures
exposed to hypoxia. The concentration of DMSO (ie,
0.02% v/v) that was used as the vehicle to dissolve MPFF
did not significantly affect the expression of HIF-1 and
HIF-2mRNA and protein in NVV and VV organ cultures
exposed to hypoxia compared with those that were not
treated with DMSO (Figs 1 and 2, respectively). Treatment
of NVV organ cultures exposed to hypoxia with doxycy-
Fig 1. A, Expression of hypoxia-inducible factor (HIF
quantitative polymerase chain reaction relative to norm
(n 6) exposed to 16 hours of hypoxia with or without t
flavonoid fraction (MPFF; 10–5 mol/L). MPFF was disso
the effects of DMSO on HIF-1 and HIF-2mRNA in N
assessed for comparison with those treated with MPFF.
One-way analysis of variance (ANOVA) with repeated m
sons, was used to calculate for any significant differences.
gene expression is presented with the individual graph.
significant. B, Representative Western blot analysis of HI
to hypoxia with and without treatment of doxycycline (5
in DMSO (0.02% v/v), and therefore, the effects of DM
hypoxia were also assessed for comparison with those
extracellular signal-regulated kinase 2 (ERK-2).cline or MPFF did not significantly alter the expression of PIF-1 and HIF-2mRNA compared with those exposed
o normoxia only (Fig 1, A). Meanwhile, treatment of VV
rgan cultures exposed to hypoxia with doxycycline also
id not significantly affect the expression of HIF-1 and
IF-2 mRNA compared with those exposed to hypoxia
nly (Fig 2, A).
However, MPFF significantly reduced the expression
f HIF-1 (P  .03) but not HIF-2 mRNA in VV organ
ultures exposed to hypoxia compared with those that were
reated with an equal amount of DMSO, vehicle control
nly (Fig 2,A). At the protein level, treatment of NVV and
V organ cultures that were exposed to hypoxia with
oxycycline orMPFF did not appear to alter the intensity of
he immunoreaction at 120 kDa, corresponding toHIF-1
nd HIF-2, compared with those that were untreated or
reated with DMSO only, respectively (n 3; Figs 1, B and
, B, respectively).
Doxycycline and MPFF do not affect HIF target
enes expression in hypoxic NVV and VV organ
ultures. Treatment of NVV and VV organ cultures that
ere exposed to 16 hours of hypoxia with doxycycline or
PFF did not significantly alter the expression of all the
IF target gene mRNA assessed (CA-9, BNIP-3,
and HIF-2 messenger RNA (mRNA) measured with
value  1) of nonvaricose vein (NVV) organ cultures
ent with doxycycline (5 g/mL) or micronized purified
n dimethyl sulfoxide (DMSO; 0.02% v/v) and therefore,
organ cultures exposed to 16 hours of hypoxia were also
are expressed as mean  standard error of the mean.
res, followed by the Dunnett test for multiple compari-
verall P value of the one-way analysis of variance for each
e of the individual comparisons between groups were
and HIF-2 of NVV organ cultures of a patient exposed
mL) or MPFF (10–5 mol/L). The MPFF was dissolved
on HIF-1 mRNA in NVV organ cultures exposed to
d with MPFF. The loading control was assessed with)-1
oxia (
reatm
lved i
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tively).
DISCUSSION
Vein wall remodeling is known to contribute to several
common pathologies involving venous tissues, including
VVs, varicocele, vein graft stenosis, and venous thrombo-
sis.3–7 Vein wall changes associated with these pathologies
include intimal hyperplasia, changes in smooth muscle cell
function, disruption of matrix metabolism, and alteration
of venous tone.3–6 Hypoxia is one of the factors that are
thought to contribute to vein wall remodeling in some of
these pathologies.3–6 Moreover, increased activity of the
HIF pathway has recently been demonstrated in some of
these pathologies, further supporting the role of hypoxia in
contributing to their pathogenesis.4,7–9
In this study, we investigated whether doxycycline and
MPFF, at a concentration corresponding to a therapeutic
dose, affect the HIF pathway of NVVs and VVs exposed to
hypoxia. We studied doxycycline and MPFF because both
agents have been reported to have protective effects on
vascular remodeling. Doxycycline has been shown to in-
Fig 2. A, Expression of hypoxia-inducible factor (HIF
quantitative polymerase chain reaction relative to normo
exposed to 16 hours of hypoxia with or without treat
flavonoid fraction (MPFF; 10–5 mol/L).MPFF was disso
the effects of DMSO on HIF-1 and HIF-2 mRNA in
assessed for comparison with those treated with MPFF.
§Significantly decreased compared with VV organ cultu
0.02% (v/v) only (P	 .05; paired t-test). One-way analys
the Dunnett test for multiple comparisons, was used to
of the one-way analysis of variance for each gene expressi
of the individual comparisons between groups were signi
HIF-2 of VV organ cultures exposed to hypoxia with
(10–5mol/L). TheMPFFwas dissolved inDMSO (0.02%
in VV organ cultures exposed to hypoxia were also assess
control was assessed with extracellular signal-regulated khibit intimal hyperplasia that may contribute to vein graft ctenosis, most likely through inhibition of MMPs.14 There
s also evidence supporting that doxycycline delays the
rogression and development of aortic aneurysm through
MP inhibition.20,21 MMPs are thought to play a signifi-
ant role in the destruction of extracellular matrix in the
ortic wall, leading to the pathogenesis of aortic aneu-
ysm.20,22 Because some of the MMPs and their tissue
nhibitors are regulated by the HIF pathway, there is a
ossibility that doxycycline may affect the HIF pathway.
eanwhile, MPFF is often used clinically to treat chronic
enous insufficiency, including improving the rate of ulcer
ealing and edema-related symptoms that have been dem-
nstrated in several randomized controlled studies.16,23,24
The concentration of doxycycline used in this study (5
g/mL) was based on previous in vivo and in vitro studies on
bdominal aortic aneurysm. In one study, 14 patients diag-
osed with abdominal aortic aneurysm were prescribed with
00 mg twice daily for at least 3 months. The levels of
irculating doxycycline analyzed with liquid chromatography
ere a mean of 4.1  0.56 g/mL (range, 1.8-9.4 g/
L).25 In another study, doxycycline (5g/mL) significantly
educed the production ofMMP-2 in vascular smoothmuscle
and HIF-2 messenger RNA (mRNA) measured with
alue  1) of varicose vein (VV) organ cultures (n  6)
with doxycycline (5 g/mL) or micronized purified
dimethyl sulfoxide (DMSO; 0.02% v/v), and therefore,
rgan cultures exposed to 16 hours of hypoxia were also
are expressed as mean  standard error of the mean.
posed to 16 hours of hypoxia and treated with DMSO
ariance (ANOVA) with repeated measures, followed by
late for any significant differences. The overall P value
resented with the individual graph. Unless stated, none
. B, Representative Western blot analysis of HIF-1 and
ithout treatment of doxycycline (5 g/mL) or MPFF
, and therefore, the effects of DMSOonHIF-1mRNA
comparison with VVs treated with MPFF. The loading
2 (ERK-2).)-1
xia (v
ment
lved in
VV o
Data
res ex
is of v
calcu
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v/v)
ed forell culture and infrarenal aortic tissue explants.26
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on in vitro studies that assessed the effects ofMPFFor diosmin
on vein cultures.27,28 In one study, MPFF at the concentra-
tion of 10–5 mol/L significantly increased the noradrenaline-
induced contractility of NVV and VV organ culture.28 In
another study, diosmin at the concentration of 0.5 to 10
mol/L shifted the Ca2
 concentration-tension response
curve to the left in chemically skinned strips from the rat
femoral vein.27 Diosmin dissolved in DMSO 	0.1% (v/v)
had no effect on the contractility of the venous tissues.27 On
the basis of the findings in these studies, MPFF at a concen-
tration of 10–5 mol/L was used. In this study, MPFF was
dissolved in DMSO to make a final concentration of 0.02%
Fig 3. Expression of six hypoxia-inducible factor (HIF)
2/adenovirus E1B 19-kDa protein-interacting protein 3 [B
[PHD-3], glucose transporter-1 [GLUT-1] and vascular e
polymerase chain reaction relative to normoxia (value  1
hypoxia with or without treatment with doxycycline (5 
mol/L). TheMPFFwas dissolved in dimethyl sulfoxide (DM
on hypoxia-inducible factor target genes in nonvaricose v
comparison with those treated with MPFF. Data are expres
variance (ANOVA) with repeatedmeasures, followed by the
any significant differences. The overallP value of one-way an
individual graph. All individual comparisons between grou(v/v) in the culture tominimize any toxicity from the solvent. tThe NVV and VV organ cultures were exposed to
ypoxia for 16 hours to demonstrate the maximum activa-
ion of the HIF pathway. This duration of inhibition of
rolyl hydroxylation and asparaginyl hydroxylation resulted
n marked HIF stabilization and activation, leading to HIF
arget gene transcription to occur while limiting the activa-
ion of the feedback regulations of HIF-1 by sustained
ypoxia. A previous study reported that 16 hours of expo-
ure of cell culture to 1% oxygen or dimethyloxallyl glycine,
nonspecific inhibitor of prolyl hydroxylase and asparaginyl
ydroxylase, show overall concordance of patterns of gene
xpression, indicating the central involvement of prolyl
ydroxylase and asparaginyl hydroxylase in the transcrip-
t genes (carbonic anhydrase-9 [CA-9], B-cell lymphoma
3], prolyl hydroxylase domain-2 [PHD-2], and domain-3
elial growth factor [VEGF]) measured with quantitative
x nonvaricose vein organ cultures exposed to 16 hours of
) or micronized purified flavonoid fraction (MPFF; 10–5
0.02% v/v), and therefore, the effects of dimethyl sulfoxide
rgan cultures exposed to hypoxia were also assessed for
s mean standard error of the mean. One-way analysis of
nett test formultiple comparisons, was used to calculate for
of variance for each gene expressionwas presentedwith the
re not significant.targe
NIP-
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Volume 56, Number 4 Lim et al 1075In this study, differences were observed between the
patients providing NVVs and VVs in age, sex, and comor-
bidities. Such differences are not uncommon in studies of
VVs because control veins are often obtained from arterial
bypass surgery during which saphenous vein is harvested for
grafting. Patients who need arterial revascularization sur-
gery frequently exhibit cardiovascular-related comorbidi-
ties, are men, and are usually older than those who undergo
VV surgery. Such variation in demographic data may be
significant or limiting in studies aiming to compare differ-
ences between NVVs and VVs. However, this was not the
case in this study because the primary aim was to assess the
Fig 4. Expression of six hypoxia-inducible factor (HIF)
2/adenovirus E1B 19-kDa protein-interacting protein
domain-3 [PHD-3], glucose transporter-1 [GLUT-1] an
quantitative polymerase chain reactions relative to norm
exposed to 16 hours of hypoxia with or without treat
flavonoid fraction (MPFF; 10–5 mol/L). The MPFF wa
therefore, the effects of dimethyl sulfoxide on hypoxia-
exposed to hypoxia were also assessed for comparison w
standard error of the mean. One-way analysis of variance
test for multiple comparisons, was used to calculate for
analysis of variance for each gene expression is presented w
between groups were significant.effects of doxycycline and MPFF on two types of vein sNVV and VV) separately when exposed to hypoxia rather
han to compare if there were differences between the two
roups.
We also included cephalic and saphenous veins in the
VV group. We have previously used these veins as NVVs
n similar studies, and they seemed to show no obvious
ifferences.8,30 However, we were unable to assess if there
ere any differences between cephalic and saphenous veins
ue to small sample size.
The upregulation of HIF-1 and HIF-2 protein and
IF target genes in NVV and VV organ cultures exposed
o hypoxia compared with those in normoxia, which was
t genes (carbonic anhydrase-9 [CA-9], B-cell lymphoma
NIP-3], prolyl hydroxylase domain-2 [PHD-2], and
cular endothelial growth factor [VEGF]) measured with
(value equal to 1) of six varicose vein organ cultures
with doxycycline (5 g/mL) or micronized purified
solved in dimethyl sulfoxide (DMSO; 0.02% v/v), and
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October 20121076 Lim et alunit.8 Furthermore, this study demonstrated that doxycy-
cline and MPFF at a concentration corresponding to ther-
apeutic dose did not significantly alter the activity of the
HIF pathway in NVV and VV organ cultures exposed to
hypoxia. Therefore, our data do not support the hypothesis
that the effects of doxycycline and MPFF on vein wall
remodeling secondary to hypoxia are dependent on the
HIF pathway.
In this study, MPFF significantly reduced the expres-
sion of HIF-1 mRNA in VV organ cultures exposed to
hypoxia, although this was not reflected at the protein level
when analyzed with Western blot. Furthermore, there was
a downregulation trend of HIF-2 mRNA and the HIF
target genes expression in VV organ cultures treated with
MPFF compared with those untreated, although this did
not achieve statistical significance. This raised the possibil-
ity of a type II error or inadequate sample size, which could
not be ruled out, although interestingly, such a downregu-
lation trend was not clear in the NVV group.
Nevertheless, the protein levels of HIF-1 andHIF-2
were not affected in NVVs or VVs, suggesting that both
treatment methods could not inhibit or attenuate the effect
of HIF- stabilization, which was the oxygen-dependent
regulation of HIF-. In other words, there was so much
HIF-1 protein being stabilized in hypoxia that the rela-
tively small but significant reduction of HIF-1 mRNA in
VVs caused by MPFF became insignificant at the protein
level. This is not surprising because oxygen-dependent
regulation of HIF-, which only occurs at the protein level,
is the most important regulatory pathway of HIF-.1,10
Some flavonoids have been shown to inhibit HIF-1
activity.29 It has also been reported that the inhibition of
HIF-1 activity by some flavonoids involves the oxygen-
independent regulation of the HIF pathways, including the
mitogen-activated protein kinase andmammalian target for
rapamycin/p70S6 kinase/4E-BP1.31,32 However, these
pathways are complex and therefore, this needs to be
further investigated before any firm conclusion about the
effects of MPFF on the HIF pathway in NVV and VV can
be made.
CONCLUSIONS
We found no evidence to support that doxycycline and
MPFF at a concentration corresponding to a therapeutic
dose alter the activation of the HIF pathway in VV and
NVV organ cultures exposed to hypoxia. Our data suggest
that although doxycycline and MPFF are known to modu-
late vein wall remodeling, their effects are likely indepen-
dent of the HIF pathway.
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